The authors would like to thank Hengli Tang (Florida State University) for the gift of the ZIKV NS5 8B8 monoclonal antibody, Kate Fitzgerald (University of Massachusetts Medical School) for providing HEK293-T3Y cells, Bryan Cullen (Duke University Medical Center) for sharing control and Dicer-knockout 293T cells, Brandy Russel (CDC, Fort Collins) for providing the PRVABC59 strain of ZIKV, Ju-Tao Guo and Jinhong Chang (Baruch S. Blumberg Institute) and Pei-Yong Shi (University of Texas Medical Branch) for sharing the DENV-1 replicon construct.